Kaitlin Sullivan, PA
Medical · Louisville, KYNPI 1710238001
Payments from drug & device makers
Across 149 payments — averaging $18.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$409
- Mayne Pharma Commercial LLC$303
- Exeltis, USA Inc.$219
- Astellas Pharma US Inc$179
- Shield Therapeutics Inc$179
- Biogen$135
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,688100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $409 |
| Mayne Pharma Commercial LLC | 22 | $303 |
| Exeltis, USA Inc. | 14 | $219 |
| Astellas Pharma US Inc | 10 | $179 |
| Shield Therapeutics Inc | 7 | $179 |
| Biogen | 6 | $135 |
| Seqirus USA Inc | 1 | $97 |
| Avion Pharmaceuticals | 7 | $90 |
| Therapeuticsmd, Inc. | 7 | $89 |
| Hologic Sales And Service, LLC | 4 | $84 |
| Aspira Women's Health Inc | 2 | $74 |
| Astellas Pharma Global Development | 1 | $65 |
| Agile Therapeutics, Inc. | 4 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $55 |
| Novo Nordisk | 3 | $51 |
| Exact Sciences | 3 | $49 |
| Myovant Sciences Inc. | 3 | $49 |
| Amgen | 3 | $47 |
| Radius Health, Inc. | 2 | $41 |
| Evofem Biosciences, Inc. | 2 | $41 |
| Organon | 3 | $39 |
| Merck | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $32 |
| Pacira Pharmaceuticals Incorporated | 2 | $31 |
| Millicent US Inc | 2 | $31 |
| Bayer | 2 | $30 |
| Mylan Pharmaceuticals Inc. | 2 | $28 |
| Scynexis, Inc. | 2 | $28 |
| Abbott | 1 | $24 |
| Bracco Diagnostics Inc. | 1 | $22 |
| Virtus Pharmaceuticals LLC | 1 | $18 |
| Pharmacosmos Therapeutics Inc. | 1 | $15 |
| Davol Inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
How this compares
$2,688 in reported general payments places this provider in the 70th percentile of 222 medical providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 29 | $1,491 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $256 |
| Fluconazole | 12 | $30 |
| Alendronate Sodium | 12 | $9 |
Paid to pharmacies, not to this prescriber.
Other medical in Louisville
- Alexandra HuettLouisville$13K
- Mitzi CarterLouisville$5K
- Kristen YoungLouisville$5K
- Kacie LawLouisville$4K
- Lindsey KraftLouisville$4K
- Elizabeth ArnoldLouisville$3K
- Kristen HordLouisville$3K
- William BriggsLouisville$3K
- Mikal BaileyPaducah$84K
- Kyle HeraldBowling Green$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.